Published :
Tables : 58
Figures : 46
Category : Healthcare
No. of Pages : 245
Report Code : HC-U3401
Facial Aesthetic Products Market Dynamics: Facial aesthetics are carried out for reinvigorating facial skin. It is a combination of facial treatments that are performed to reduce glabella lines and wrinkles as well as reinvigorate the face skin. The adoption of facilities for medical aesthetics is a rational initial step for females as it is cheaper, easy, and brisk. These products have proven to be advantageous for patients who are satisfied with temporary medical care. There has been a significant rise in the regular net income of facial aesthetics which has enabled skin care clinics, restorative experts, or dermatology clinics in continuing their endorsement for facial injectables like Botox and dermal fillers to patients. Botox is prominently popular among women and men as it highly effective in restoring the youthfulness of skin. Facial Aesthetic Products Market Segmentation: By Product Dermal Fillers Particle and Polymer Fillers Botox By End User Hospitals Aesthetic Clinics Beauty Salon By Region North America Europe Asia Pacific Latin America Middle East & Africa The market is fragmented into product, end user and region. The product segment is categorized into dermal fillers, particle and polymer fillers, Botox, and others. The Botox segment is predicted to hold the largest facial aesthetics products market share owing to the rising demand of men and women wanting to reduce wrinkles and rejuvenate the skin for a youthful appearance, especially from celebrities and public figures, who have indirectly endorsed the usage of such facial aesthetic products. The end user segment is classified into hospitals, aesthetic clinics and beauty salon. The hospital segment is anticipated to lead the market owing to advancements in hospital infrastructure, rise in the number of multispecialty hospitals across the world and availability of skilled healthcare professionals. Regional Analysis: The North America region is projected to dominate the market owing to the rising geriatric population, increased disposable income, a strong presence of major market players, growing awareness pertaining to aesthetic procedures, growing healthcare expenditure and the early emergence of advanced aesthetic processes. Competitive Landscape: Some of the prominent market players are Novartis AG, Mentor Worldwide LLC, ALLERGAN, Valeant Pharmaceuticals International Inc., Merz Pharma, Anika Therapeutics, MD Skin Solutions, Galderma, and Nestlé Skin Health. FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global facial aesthetic products market by product, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Facial aesthetics are carried out for reinvigorating facial skin. It is a combination of facial treatments that are performed to reduce glabella lines and wrinkles as well as reinvigorate the face skin. The adoption of facilities for medical aesthetics is a rational initial step for females as it is cheaper, easy, and brisk. These products have proven to be advantageous for patients who are satisfied with temporary medical care. There has been a significant rise in the regular net income of facial aesthetics which has enabled skin care clinics, restorative experts, or dermatology clinics in continuing their endorsement for facial injectables like Botox and dermal fillers to patients. Botox is prominently popular among women and men as it highly effective in restoring the youthfulness of skin.
Facial Aesthetic Products Market Segmentation:
By Product
By End User
By Region
The market is fragmented into product, end user and region. The product segment is categorized into dermal fillers, particle and polymer fillers, Botox, and others. The Botox segment is predicted to hold the largest facial aesthetics products market share owing to the rising demand of men and women wanting to reduce wrinkles and rejuvenate the skin for a youthful appearance, especially from celebrities and public figures, who have indirectly endorsed the usage of such facial aesthetic products. The end user segment is classified into hospitals, aesthetic clinics and beauty salon. The hospital segment is anticipated to lead the market owing to advancements in hospital infrastructure, rise in the number of multispecialty hospitals across the world and availability of skilled healthcare professionals.
Regional Analysis:
The North America region is projected to dominate the market owing to the rising geriatric population, increased disposable income, a strong presence of major market players, growing awareness pertaining to aesthetic procedures, growing healthcare expenditure and the early emergence of advanced aesthetic processes.
Competitive Landscape:
Some of the prominent market players are Novartis AG, Mentor Worldwide LLC, ALLERGAN, Valeant Pharmaceuticals International Inc., Merz Pharma, Anika Therapeutics, MD Skin Solutions, Galderma, and Nestlé Skin Health.
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outloo 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Facial Aesthetic Products Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Dermal Fillers 7.2 Particle and Polymer Fillers 7.3 Botox 8. Facial Aesthetic Products Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Hospitals 8.2 Aesthetic Clinics 8.3 Beauty Salon 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Novartis AG 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Mentor Worldwide LLC 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 ALLERGAN 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Valeant Pharmaceuticals International Inc. 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Merz Pharma 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Anika Therapeutics 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 MD Skin Solutions 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Galderma 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Nestlé Skin Health 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16 Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at FutureWise Market Research
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics